Login
Home / 1789.TW : TAI
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

ScinoPharm Taiwan, Ltd.

TWD 18.1 +$0.95 (+5.54%)
TAI · 15 Sep 2026 05:30 UTC
Previous Close
TWD 18
Day Range
TWD 17.9TWD 18.1
Year Range
TWD 16.7TWD 29.1
Market Cap
14.31B
AVG Volume
732.22K
Trailing/Forward PE
380.25/39.35
PEG ratio
7.86
Dividend Yield
1.60%
Next Earnings Date
2026-11-10
Primary Exchange
Taiwan Stock ExchangeTW
Revenue (TWD)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (TWD)
-50M050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (TWD)
-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (TWD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (TWD)
-100M0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (TWD)
-0.100.10.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (TWD)
0200M400M600MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (TWD)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-6-4-2024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-0.5%0%0.5%1%1.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (TWD)
00.20.40.6Aug 17Jul 18Jul 19Jul 20Aug 21Jul 22Jul 23Jul 24Jul 25Jul 26
Book Value Per Share (TWD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (TWD)
05B10B15B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
050100150200med 65.3Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
1%2%3%4%med 1.74%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
34567med 5.09Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
10152025med 16Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
1020304050med 27.89Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
1.21.41.61.82med 1.56Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
ScinoPharm Taiwan, Ltd.
1789.TW
Stockpicker

Video analysis: 1789.TW

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.